Intuitive Surgical (NASDAQ:ISRG) VP Sells $65,829.68 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) VP Fredrik Widman sold 133 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the transaction, the vice president directly owned 660 shares of the company’s stock, valued at $326,673.60. This represents a 16.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Intuitive Surgical Stock Up 1.5%

NASDAQ ISRG opened at $485.84 on Friday. The firm has a market capitalization of $172.54 billion, a PE ratio of 61.58, a P/E/G ratio of 3.71 and a beta of 1.65. The stock’s 50 day moving average is $541.62 and its 200 day moving average is $510.24. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same quarter last year, the firm posted $2.21 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. SteelPeak Wealth LLC raised its stake in Intuitive Surgical by 28.7% during the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after purchasing an additional 9,364 shares during the period. Atlantic Union Bankshares Corp boosted its stake in Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock worth $10,179,000 after purchasing an additional 3,676 shares during the period. Amalgamated Bank grew its holdings in Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after buying an additional 1,772 shares in the last quarter. Bessemer Group Inc. raised its position in shares of Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after buying an additional 371,806 shares during the last quarter. Finally, World Investment Advisors lifted its holdings in shares of Intuitive Surgical by 238.3% in the third quarter. World Investment Advisors now owns 5,399 shares of the medical equipment provider’s stock worth $2,415,000 after buying an additional 3,803 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. Robert W. Baird lowered their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating for the company in a report on Friday, January 23rd. UBS Group reiterated a “neutral” rating on shares of Intuitive Surgical in a research note on Thursday, January 15th. Argus dropped their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Leerink Partners raised their price target on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn lifted their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $617.23.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.